Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance

被引:46
作者
Pituch, H
Brazier, JS
Obuch-Woszczatnski, P
Wultanska, D
Meisel-Mikolajczyk, F
Luczak, M
机构
[1] Med Acad Warsaw, Dept Med Microbiol, PL-02004 Warsaw, Poland
[2] Univ Hosp Wales, Natl Publ Hlth Serv Microbiol Cardiff, Anaerobe Reference Lab, Cardiff, Wales
关键词
D O I
10.1099/jmm.0.46213-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Isolates (79 in total) of Clostridium difficile obtained over a 2 year period from 785 patients suspected of having C. difficile-associated diarrhoea (CDAD) and being hospitalized in the University Hospital in Warsaw were characterized by toxigenicity profile and PCR ribotyping. Furthermore, their susceptibility to clindamycin and erythromycin was determined. Among the 79 C. difficile isolates, 35 were classified as A(+)B(+), 1 as A(+)B(+)CDT(+), 36 as A(-)B(+) and 7 as A(-)B(-). A total of 21 different PCR ribotypes was detected. Two main A(+)B(+) strains circulated in our hospital: ribotype 014 and ribotype 046. Unexpectedly, the predominant PCR ribotype was type 017, a known A(-)B(+) strain, and this accounted for about 45(.)5% of all isolates cultured from patients with CDAD. Isolates belonging to PCR ribotype 017 were found in cases from epidemics of antibiotic-associated diarrhoea in the internal and surgery units. High-level resistance (MIC >= 256 mg I-1) to clindamycin and erythromycin was found in 39 (49 %) of the C. difficile isolates. Interestingly, 34 (94%) of macrolide-lincosamide-streptogramin B (MLSB) type resistance strains did not produce toxin A, but produced toxin B and were A(-)B(+) ribotype 017. Thirty-seven of the high-level resistance strains harboured the erythromycin-resistance methylase gene (ermB). C. difficile isolates (2/29) that had high-level clindamycin and erythromycin resistance, and belonged to PCR ribotype 046, were ermB negative. These investigations revealed that the predominant C. difficile strain isolated from symptomatic patients hospitalized in University Hospital in Warsaw was MLSB-positive clindamycin/erythromycin-resistant PCR ribotype 017.
引用
收藏
页码:207 / 213
页数:7
相关论文
共 27 条
[1]   Prevalence and association of macrolide-lincosamide- streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile [J].
Ackermann, G ;
Degner, A ;
Cohen, SH ;
Silva, J ;
Rodloff, AC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) :599-603
[2]   Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea [J].
Alfa, MJ ;
Kabani, A ;
Lyerly, D ;
Moncrief, S ;
Neville, LM ;
Al-Barrak, A ;
Harding, GKH ;
Dyck, B ;
Olekson, K ;
Embil, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) :2706-2714
[3]   Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France [J].
Barbut, F ;
Lalande, V ;
Burghoffer, B ;
Thien, HV ;
Grimprel, E ;
Petit, JC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :2079-2083
[4]   Pathogenesis of Clostridium difficile infection [J].
Borriello, SP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 :13-19
[5]  
Brazier JS, 1999, J HOSP INFECT, V42, P248
[7]   The macrolide-lincosamide-streptogramin B resistance determinant from Clostridium difficile 630 contains two erm(B) genes [J].
Farrow, KA ;
Lyras, D ;
Rood, JI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :411-413
[8]   Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile [J].
Farrow, KA ;
Lyras, D ;
Rood, JI .
MICROBIOLOGY-SGM, 2001, 147 :2717-2728
[9]  
Gerding DN, 2001, EMERGING INFECTIONS 5, P111
[10]   Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. [J].
Johnson, S ;
Samore, MH ;
Farrow, KA ;
Killgore, GE ;
Tenover, FC ;
Lyras, D ;
Rood, JI ;
DeGirolami, P ;
Baltch, AL ;
Rafferty, ME ;
Pear, SM ;
Gerding, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (22) :1645-1651